Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The New England journal of medicine, 2002-11, Vol.347 (22), p.1805-1805
Ort / Verlag
United States: Massachusetts Medical Society
Erscheinungsjahr
2002
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
To the Editor:
The patient with systemic lupus erythematosus and tuberculosis described in the Clinical Problem-Solving article by Haberer et al. (May 2 issue)
1
could have been identified as being at high risk for reactivation of tuberculosis before the initiation of immunosuppressive therapy. Isoniazid prophylaxis has been reported to be effective and safe in patients with systemic lupus erythematosus and might have been considered when the immunosuppressive therapy was started.
2
,
3
This case underscores the importance of assessing the risk of infectious complications in immunocompromised patients.